Waldencast Acquisition Corp. ( (WALD) ) has released its Q1 earnings. Here is a breakdown of the information Waldencast Acquisition Corp. presented to its investors.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Waldencast Acquisition Corp. is a global multi-brand beauty and wellness platform, known for developing, acquiring, and scaling purpose-driven brands in the beauty industry.
In its Q1 2025 earnings report, Waldencast reported a net revenue of $65.4 million, marking a 4.1% decline from the previous year. Despite the revenue drop, the company achieved a 76.4% adjusted gross margin, showing a slight improvement.
Key highlights from the report include a strong performance by the Obagi Medical brand, which saw a 7.1% increase in net revenue, driven by direct-to-consumer channels. Milk Makeup, however, experienced a 15.1% decline in net revenue due to inventory reductions and challenging comparisons with the previous year’s successful product launches. The brand’s expansion into Ulta Beauty and the launch of Hydro Grip Gel Tint were notable successes.
Waldencast’s financial strategy included securing a new $205 million credit facility to enhance financial flexibility. The company ended the quarter with $10.8 million in cash and a net debt of $172.1 million.
Looking ahead, Waldencast remains optimistic about its growth prospects, anticipating stronger performance in the upcoming quarters, driven by new product innovations and improved supply chain efficiencies.